Vazzano Joseph Walter 4

What Happened
Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics, sold 24,880 shares of ABEO in open-market transactions on July 9, 2026. The weighted-average sale price was $6.96, for total proceeds of approximately $173,257. This was a sale (routine disposition) rather than a purchase or exercise.

Key Details

• Transaction date: 2026-07-09 (Form 4 filed same day — timely)
• Transaction type/code: Open-market sale (S)
• Shares sold: 24,880; weighted-average price: $6.96; price range: $6.86 to $7.04 (multiple trades)
• Reported reason: Sale was to cover tax obligations associated with vesting of restricted stock awards (footnote F1)
• Footnote on pricing: Weighted average reported; reporting person can provide per-trade breakdown on request (footnote F2)
• Shares owned after transaction: Not specified in this Form 4

Context
Sales to satisfy tax withholding on vested restricted stock are common and are generally considered routine liquidity events rather than a direct signal about the insider’s view of the company. Purchases by insiders tend to be more informative about confidence in the stock; this filing documents a cash-raising sale tied to compensation tax obligations.